Vaxcyte Inc (PCVX)

SG&A Expenses

$132.67M

TTM · Period ending: · USD

PCVX logo

PCVX SG&A Expenses

Latest reported$132.67M
PCVX TTM SG&A Expenses ($8.55M → $132.67M)
High-resolution chart · PNG

PCVX sg&a expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Vaxcyte Inc SG&A Expenses — Trailing twelve months (TTM) (USD)
Period endingSG&A Expenses (USD)
132,666,000
129,781,000
129,369,000
125,701,000
116,242,000
105,676,000
92,902,000
81,873,000
74,490,000
67,472,000
60,699,000
55,125,000
50,418,000
45,379,000
39,810,000
34,630,000
30,255,000
26,917,000
25,259,000
23,279,000
21,654,000
18,621,000
16,017,000
13,682,000
11,294,000
10,512,000
8,547,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.